Combined assessment of the MYD88 L265P mutation, IL‐10 levels and PCR for Ig heavy chain variable (IgVH) rearrangement in the CSF allows efficient discrimination of PCNSL from glial neoplasms and non‐neoplastic disorders of the CNS.14 This evidence concerns the gene MYD88 and glioma.